0001225208-12-022175.txt : 20121101 0001225208-12-022175.hdr.sgml : 20121101 20121101180821 ACCESSION NUMBER: 0001225208-12-022175 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20121031 FILED AS OF DATE: 20121101 DATE AS OF CHANGE: 20121101 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lewis-Hall Freda C CENTRAL INDEX KEY: 0001437909 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03619 FILM NUMBER: 121174640 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PFIZER INC CENTRAL INDEX KEY: 0000078003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 135315170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 235 E 42ND ST CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2125732323 MAIL ADDRESS: STREET 1: 235 E 42ND ST CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: PFIZER CHARLES & CO INC DATE OF NAME CHANGE: 19710908 4 1 doc4.xml X0306 4 2012-10-31 0000078003 PFIZER INC PFE 0001437909 Lewis-Hall Freda C PFIZER INC.-CORP. SECRETARY 235 EAST 42ND ST. NEW YORK NY 10017 1 Executive Vice President Phantom Stock Units SSP 2012-10-31 4 A 0 63.0000 24.8700 A Common Stock 63.0000 10028.0000 D Each unit represents one phantom share of common stock. These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Lawrence A. Fox, by power of atty., for Freda C. Lewis-Hall 2012-11-01